Pain Specialty Group
- Ketamine Therapy
- Arthritis Treatment
- Stem Cell Therapy
Read the Ketamine Therapy guide for the educational context behind this treatment category.
New Hampshire
Ketamine therapy in New Hampshire is concentrated in the southern tier of the state. Manchester and Nashua, near the Massachusetts border, carry most of the supply, and Concord, the state capital, also has treatment services, so a search for ketamine treatment in Concord, NH should turn up local options. The Seacoast area around Portsmouth adds another point of access. Coverage thins out quickly moving north: the Lakes Region, the White Mountains, and the North Country have little or no dedicated ketamine therapy, and residents there should expect to travel south within New Hampshire, or sometimes into Massachusetts, for an in-person evaluation or an infusion series.
New Hampshire does not have a ketamine-specific statute separate from general medical practice law. Ketamine for depression is typically administered off-label in a physician office or a monitored infusion suite, with a prescriber responsible for the treatment plan and trained staff present during dosing and recovery. Esketamine nasal spray follows its own FDA-approved protocol with required in-office monitoring. Scope of practice for who may prescribe, order, or administer varies by license type, so ask any New Hampshire provider directly who is responsible for your evaluation and who is in the room during treatment.
To check a provider's standing, contact the New Hampshire Board of Medicine for physicians and physician assistants, or the New Hampshire Board of Nursing for nurses and advanced practice registered nurses. A license lookup confirms whether someone is currently licensed and shows any public disciplinary history; it does not tell you how much ketamine experience a provider has or whether the setting is right for you. Before booking anywhere in the state, ask who supervises dosing, what medication is used and where it comes from, how risks are explained in writing, what happens if treatment does not help, and for an itemized quote covering evaluation, medication, monitoring, and psychotherapy.
The national ketamine therapy hub covers the mechanism and the evidence in more depth, including how IV ketamine differs from esketamine. On this page, listing order is not sold, Featured placements are labeled and capped, Verified means a clinic completed credential checks rather than paid for visibility, and Regenerated.com is free for patients. Being listed here is not an endorsement. For more on how to compare listings, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
New Hampshire enforces federal scheduling. The New Hampshire Board of Medicine oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. New Hampshire PDMP requires controlled substance reporting.
Explore by location
Treatment nearby
More in this state
Nationwide
Ketamine Therapy clinics across the US